Biomarx logo
biomarx.co.uk
Actively hiring
Precision Medicine
Health Care
Molecular Diagnostics
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
51-200
employees, estimated range
Backers
2
Clarendon Fund Managers, SFC Capital
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Clarendon Fund Managers 
SFC Capital Investors in similar startupsfunds that back the companies most like this one
backs Clear Labs
backs DELFI Diagnostics
Similar startupsby what they do, their industry and backers
Hepta is decoding tissue-level biology from blood, starting with MASH. LiquidTransformer, our liquid biopsy-native AI platform, reads…
Precious MD is developing a companion diagnostic to identify the lung cancer patients who benefit from receiving EGFR inhibiting ...
Altum Sequencing delivers ultra-sensitive ctDNA detection for cancer monitoring and MRD assessment. Precision liquid biopsy solutions for…
Anvil Diagnostics develops MycoScan™, a rapid 3-hour pan-fungal liquid biopsy for invasive fungal infections using proprietary SKIP-Seq™…
Oncology Research. Automated genomic solutions for oncology.
Combining the power of liquid biopsy and AI-driven epigenetics, we deliver accurate cancer detection. Our approach transforms diagnostics…
Overview
Biomarx delivers rapid, low-cost, fully automated liquid biopsy — genomic-grade cancer answers from a blood test in under 2 hours, starting with lung cancer.